Association of statins and nivolumab activity in patients with metastatic renal cell carcinoma (mRCC): Results from the phase II nivoren—GETUG AFU 26 trial.
暂无分享，去创建一个
B. Escudier | S. Oudard | G. Gravis | F. Joly | P. Barthélémy | S. Ladoire | R. Flippot | A. Thiery-Vuillemin | C. Chevreau | L. Albiges | B. Laguerre | L. Geoffrois | S. Négrier | C. Dalban | F. Rolland | E. Colomba | M. Goupil | F. Tantot